Mayo Clinic

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).

2,844 total trials 544 currently recruiting 1816 completed early-phase tilt top decile by trial count

Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.

Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.

Top-decile sponsor footprint

Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

2,844 total, page 46 of 57

COMPLETED NA

Improving Maintenance Following Very Low Calorie Diet: The Sustain Lost Weight (SLW) Intervention

NCT01222988
COMPLETED Phase 1

Assessment of Coronary Plaque Composition Using Optical Coherence Tomography

NCT01642173
COMPLETED

Non-Invasive EndoPAT Increases Diagnostic Yield of CAD by Coronary Angiography

NCT01581671
COMPLETED NA

A Psychological and Behavioral Intervention for Post-Bariatric Patients

NCT01453517
COMPLETED Phase 1

Tobacco Cessation Treatment for Alaska Native Youth

NCT01099384
COMPLETED NA

Multicomponent Intervention to Decrease Chronic Obstructive Pulmonary Disease (COPD)-Related Hospitalizations

NCT01058486
COMPLETED Phase 1

Acetaminophen Transfer Across the Placenta and the Assessment of Fetal Well-being

NCT01211912
COMPLETED Phase 1

Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes

NCT01203592
COMPLETED Phase 1

Decision Aid Development for Smokers

NCT01193972
COMPLETED NA

Short-Term Fasting Before Chemotherapy in Treating Patients With Cancer

NCT01175837
COMPLETED NA

Integrated Behavioral Intervention for Cigarette Smoking and Binge Drinking in Young Adults

NCT01184261
COMPLETED

Endoscopic Submucosal Dissection Registry

NCT01415609
COMPLETED NA

Endoscopic Quality Improvement Program

NCT01415817
COMPLETED

Validation Study of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

NCT02158637
COMPLETED

Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants

NCT02366286
COMPLETED Early Phase 1

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

NCT01165632
COMPLETED Phase 2

Highdose Nicotine Patch Therapy for Smokeless Tobacco Use

NCT00939029
COMPLETED NA

Potential Impact of Polycystic Ovarian Syndrome on Protein Modifications and Accumulation

NCT02105428
COMPLETED

Biomarkers in Aortic Stenosis - B.A.S.S.

NCT01334801
COMPLETED NA

Prospective Study of Undiagnosed Celiac Disease

NCT01317914
TERMINATED NA

Ultrasound Image Fusion for Placement of Sacral Quadripolar Leads

NCT01054534
COMPLETED Phase 2

Trial Evaluating the Effect of Facilitated Small Group Sessions on Physician Well-Being, Job Satisfaction, and Professionalism

NCT01159977
COMPLETED Phase 1

Influence of Male Hormones on Regional Fat Metabolism

NCT01160328
COMPLETED

Early Increase in Blood Supply in Patients With Barrett's Esophagus

NCT01188980
COMPLETED NA

Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer

NCT01015820
COMPLETED Phase 1

Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS)

NCT01142856
COMPLETED Phase 2

Rapid Easy Strength Training (REST) to Improve Function in Late Stage Cancer

NCT01334983
COMPLETED NA

Wait-list Study of One-Week Intensive Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder (OCD)

NCT01194076
COMPLETED Phase 4

Tricuspid Regurgitation Study

NCT01093001
COMPLETED Phase 2

A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus)

NCT01206582
COMPLETED Phase 1

Oxazyme in Patients With Hyperoxaluria

NCT01127087
TERMINATED Phase 1

Eculizumab to Prevent Antibody-mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation

NCT01095887
COMPLETED Phase 4

The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids.

NCT00995878
COMPLETED Phase 1

Assessment of Combined Bowel Preparation for Capsule Endoscopy Study

NCT01243736
COMPLETED

Finger Hardness Measure in Scleroderma

NCT01111786
COMPLETED

Pilot to Assess DBE as a Rescue Technique for Failed PEJ

NCT01057940
COMPLETED Phase 1

Intestinal Microecology in Chronic Constipation

NCT00934479
COMPLETED NA

Impact of Decision Aids to Enhance Shared Decision Making for Diabetes

NCT01029288
TERMINATED NA

Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as Adjuvant Treatment for Depression

NCT01115699
COMPLETED NA

Trendelenburg's Slide Prevention Study

NCT01068821
COMPLETED

Fat Biology, Sleep Disorders, and Cardiovascular Disease

NCT01229501
COMPLETED NA

Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus

NCT01080326
COMPLETED NA

Evaluating Transcutaneous Electrical Nerve Stimulation for Postoperative Pain After Video-Assisted Thoracotomy Surgery

NCT01046695
COMPLETED Phase 2

A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome

NCT00977197
COMPLETED Phase 1

Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma

NCT01057225
COMPLETED Phase 4

Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?

NCT01093755
COMPLETED Phase 4

Pregabalin and Colonic Function

NCT01094808
COMPLETED

Use of Low-dose Molecular Breast Imaging for the Detection of Small Breast Lesions

NCT01285440
COMPLETED Phase 2

Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01024010
COMPLETED Phase 1

PiB PET Scanning in Speech and Language Based Dementias

NCT01623284
← Previous Page 46 of 57 Next →

Phase Distribution

PhaseTrial count
Phase 1 435
Phase 2 386
Phase 3 86
Phase 4 166

Therapeutic Areas

Healthy 36
Malignant Solid Neoplasm 35
Obesity 31
Breast Cancer 25
Breast Carcinoma 21
Hematopoietic and Lymphatic System Neoplasm 20
Hematopoietic and Lymphoid System Neoplasm 12
Heart Failure 11
Cancer 11
Prostate Carcinoma 9

What is open in the Mayo Clinic pipeline

544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).

Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).

Top condition: Healthy (36 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Related

Compare saved trials side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.